Regeneron Gets A Win With Eylea Approval In Diabetic Retinopathy

 
• By Jessica Merrill
  
Close-up of blue eye. High Technologies in the futuristic. : cataract
Eylea has a dosing advantage, but a new competitor coming soon
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip